
DISEASE MANAGEMENT
Velaglucerase alfa
What is velaglucerase alfa?
Velaglucerase alfa is an intravenous enzyme replacement therapy for Gaucher disease.
INTRODUCING
The introduction of enzyme replacement therapy and substrate reduction therapy has enhanced the management of Gaucher disease.
Imiglucerase is an intravenous enzyme replacement therapy for Gaucher disease.1 The mechanism of action of imiglucerase is presented in Figure 1. For further information on imiglucerase, please consult your local prescribing information.
Figure 1.
Mechanism of action of imiglucerase1,2
C-ANPROM/INT//7568; Date of preparation: September 2020
DISEASE MANAGEMENT
What is velaglucerase alfa?
Velaglucerase alfa is an intravenous enzyme replacement therapy for Gaucher disease.
DISEASE MANAGEMENT
What is taliglucerase alfa?
Taliglucerase alfa is an intravenous enzyme replacement therapy for Gaucher disease.
DISEASE MANAGEMENT
What enzyme replacement therapies are available for Gaucher disease?
Three long-term enzyme replacement therapies are available for patients with Gaucher disease: imiglucerase, velaglucerase alfa and taliglucerase alfa.
Register
Registration gives the benefit of site update emails and additional information on new education materials and events